Japan Intellectual Property Rights: THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

Japan, Jan. 15 -- ASTELLAS PHARMA INC,TRON- TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ GEMEINNUETZIGE GMBH has got intellectual property rights for 'THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER.' Other related details are as follows:

Application Number: JP,2024-017596

Category (FI): A61K39/395@D,A61K39/395@N,A61K39/395@T,A61K45/00,A61P1/00,A61P35/00,A61P35/04,C07K16/30,C12N15/12,C12N15/13,G01N33/53@Y,G01N33/574@A,G01N33/574@B,G01N33/574@E,G01N33/57505,G01N33/5751,G01N33/57515,G01N33/5752,G01N33/57525,G01N33/5753,G01N33/57535,G01N33/5754,G01N33/57545,G01N33/57555,G01N33/575@A,G01N33/575@B,G01N33/575@E

Stage: Grant (IP right document published.)

Filing Date: Feb. 8, 2024

Publication Date: April 23, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.